Introduction
============

Fullerenes are a new kind of organic compounds, consisting of carbon atoms with very attractive photo-, electrochemical and physical properties that can be used in many biological fields, which make fullerenes potential therapeutic agents for a wide range of applications in nanomedicine ([@B4]; [@B16]; [@B13]). With respect to its electron donor and acceptor capability fullerenes can be effective antioxidants and radical scavengers ([@B10]; [@B7]). It was shown that under the influence of light, fullerene acts as a prooxidant ([@B32]), generating singlet oxygen ([@B10]), which can be used in photodynamic therapy of cancer and other diseases. Some fullerene derivatives exhibit inhibitory activity against human immunodeficiency virus reverse transcriptase and hepatitis C virus RNA polymerase ([@B39]; [@B44]), and can stabilize immune effector cells to prevent or inhibit the release of proinflammatory mediators, making them potential candidates for a variety of diseases, such as asthma, arthritis, and multiple sclerosis ([@B16]). Thus, fullerenes and their derivatives are excellent candidates for multiple functionalization.

It is known, that muscle fatigue is accompanied by ionic changes in action potentials ([@B2]) along with various metabolic disturbances in skeletal muscles, when reactive oxygen species (ROS) are formed ([@B25]), excess lactic acid (LA) ([@B61]), and lipid peroxidation ([@B79]). With excessive accumulation of these substances, oxidative stress occurs, which leads to significant functional disorders since various components of cells may be damaged. The damage could include changes in protein structures, nitrogenous bases, and destruction of membranes ([@B49]). Muscle cells contain endogenous cellular defense mechanisms in the form of enzymatic and non-enzymatic antioxidants that can partially eliminate ROS ([@B70]; [@B8]). A changes in the level of enzymes (*SOD GPx*, and *CAT*) under loading was observed in both animals and humans ([@B67]). During exhausted loads, the amount of *SOD* increased in skeletal muscle ([@B50]), whereas the level of *GPX* activity had not changed ([@B11]) or was increased ([@B50]). Similar phenomena were observed concerning *CAT* activity when no changes were observed during exercise ([@B46]), and there was an increase in activity under certain loads ([@B30]). Thus, the understanding of the mechanisms involved in the process of increasing antioxidant enzymes during exhaustive exercise has yet to be under debate.

Intense muscle loading contributes to rise of oxidative stress in muscle tissue ([@B50]). The presence of ROS inhibits the tricarboxylic acids cycle and disrupts the mitochondria electronic transport chain ([@B29]). With intense physical activity, the rate of hydrolysis of ATP may exceed the rate of its resynthesis, which leads to a decrease in ATP and the formation of muscle fatigue effects ([@B23]; [@B60]). However, the synthesis of ATP during training can be supported by antioxidants supplementation, which accelerate the process of muscle recovery after fatigue. There are evidences demonstrated a moderately beneficial effect of NAC ([@B76]; [@B62]) and β-Alanine ([@B74]; [@B22]; [@B75]; [@B64]) supplementation for exercise with a substantial contribution from oxidative metabolism. It was shown unspecific antioxidant activity of NAC with increase GSH synthesis and reduce muscle-derived ROS levels during contraction ([@B62]). Another study suggested a delay accumulation of lactate during exercise and increasing time to exhaustion under β-Alanine supplementation ([@B75]). In our previous study, we showed a facilitation effect of water-soluble C~60~ fullerenes on the removal of some symptoms of skeletal muscle fatigue ([@B55]). So, we consider that because of novel field of C~60~ fullerenes application (muscle fatigue) it was important to assessed the adequacy and efficiency of C~60~ fullerene protective properties against oxidative damage in comparison with the action of known antioxidant NAC and β-Alanine. It was hypothesized that due to its unique chemical structure and bioactivity a water-soluble C~60~ fullerenes would have predominant influence on prooxidant-antioxidant homeostasis of rat muscle tissue. In our the previous work we detected the effect of the C~60~ fullerenes in the short-term period after intramuscular injection ([@B55]), in this study we determined the most optimal way of its application and investigated the effect of C~60~ fullerenes after preliminary administration, which implies its preventive use in case of muscular fatigue.

Materials and Methods {#s1}
=====================

Material Preparation and Characterization
-----------------------------------------

A highly stable C~60~FAS at a maximum concentration of 0.15 mg/ml was prepared as described earlier ([@B63]; [@B59]). Briefly, for the preparation of C~60~FAS we used a saturated solution of pristine C~60~ fullerene (purity \>99.99%) in toluene with a C~60~ molecule concentration corresponding to maximum solubility near 2.9 mg/ml, and the same amount of distilled water in an open beaker. The two phases formed were treated in ultrasonic bath. The procedure was continued until the toluene had completely evaporated and the water phase became yellow colored. Filtration of the aqueous solution allowed to separate the product from undissolved C~60~ fullerenes.

DLS Measurements
----------------

Measurements of the hydrodynamic size distribution for C~60~ fullerenes in aqueous solution were performed by dynamic light scattering (DLS) on a Zetasizer Nano-ZS90 (Malvern, Worcestershire, United Kingdom) at room temperature. A DLS instrument equipped with a HeNe laser (max 5 mW) operating at a wavelength of 633 nm was used. The measurements were performed at a 90° scattering angle. The autocorrelation function of the scattered light intensity was analyzed with Static Light Scattering software.

Zeta Potential Measurements
---------------------------

Zeta potential measurements for C~60~FAS were carried out on a Zetasizer Nano-ZS90 (Malvern, Worcestershire, United Kingdom) at room temperature. The results were evaluated using the Smoluchowski approximation, which is known to be valid only for spherical-like particles.

Procedure and Experimental Groups
---------------------------------

Experiments were performed on male Wistar rats weighing 280--350 g with ages ranging from 4 to 6 months. The animals were purchased from a state-controlled animal farm through the common animal facility of Bogomoletz Institute of Physiology (Kyiv). The experimental animals were housed in Plexiglas cages (four rats per cage) and kept in an air-filtered and temperature-controlled (20--22°C) room. The rats received a standard pellet diet and water *ad libitum*. The present study was approved by the Ethics Committee of the Institute and performed according to the European Communities Council Directive of November 24, 1986 (86/609/EEC).

All animals were randomly divided into 7 groups: 1st -- fatigue-induced animals (*n* = 6); 2nd -- vehicle-injected \[fatigue-induced rats with a preliminary intraperitoneal (i.p.) injection of 0.3 ml of saline solution, *n* = 6\]; 3rd -- C~60~FAS-injected \[F-injection; fatigue-induced rats with a preliminary i.p. injection of 0.3 ml (0.14 mg/kg) of C~60~FAS, *n* = 6\]; 4th -- animals with oral administration of C~60~FAS \[F-drinking; fatigue-induced rats with a preliminary (within 5 days, 0.225 mg/kg per day) oral introduction of C~60~FAS, *n* = 6\]; 5th -- NAC-injected (fatigue-induced rats with a preliminary i.p. injection of 150 mg/kg of NAC dissolved in saline solution, *n* = 6); 6th -- β-Alanine-injected (β-Al-injection; fatigue-induced rats with a preliminary i.p. injection of 110 mg/kg of β-Alanine dissolved in saline solution, *n* = 6); and 7th -- intact animals (rats were used only for biochemical studies, *n* = 6).

It should be noted that the toxicity of the pristine C~60~ fullerenes is strictly dependent on their size (the degree of aggregation in the water). In our previous works ([@B52], [@B54]; [@B78]), we investigated in detail the *in vitro* toxicity of C60FAS. We can conclude that at a maximum concentration of 0.15 mg/ml, C60FAS (the diameter of nanoparticles is up to 50 nm) does not exhibit any genotoxicity and cytotoxicity to various types of cells, including human ones. It is important to note that the doses of C~60~FAS used in this study do not present any acute or subacute toxicity in animals: they were significantly lower than the maximum tolerated dose of pristine C~60~ fullerene, which was found to be 5 g/kg both for oral or i.p. administration to rats ([@B21]). Toxic or lethal effects were not observed in the studies of the impact of C~60~ fullerenes after oral administration to rats at a total dose of 2 g/kg for 14 days ([@B43]). Moreover, according to our previous data ([@B78]) C~60~FAS at the concentrations up to 24 μg/ml does not manifest any *in vitro* toxic effect on human mesenchymal stem cells. C~60~FAS (0.1 mg/ml) does not induce DNA strand breaks in the human lymphocytes as revealed by the comet assay ([@B54]). Finally, the authors ([@B77]) state that oral exposure of pristine C~60~ fullerene nanoparticles does not lead to major adverse effects because they were not mutagenic and genotoxic in experimental research. The pristine C~60~ fullerene is characterized by low toxicity and it does not pose a risk in the occupational environment.

Fatigue of the *TS* of rat was induced by electrical stimulation of *n. tibialis*. C~60~FAS, NAC, β-Alanine or saline solution were administered 1 h prior to electrical stimulation. After the experiment, the *TS* of all animals in all groups were removed for biochemical analysis.

The animals were anesthetized with ketamine (100 mg/kg "Pfizer", United States) combined with xylazine (10 mg/kg, "Interchemie," Holland), tracheostomized and artificially ventilated (out of necessity). The left and right *TS* muscles were separated from the surrounding tissue, their tendons were detached at the distal insertions, and a small bone chip from the heel was left behind. The *n. tibialis* was separated from the tissue and cut proximally, and all branches of the nerve, except nerves innervating the *TS*, were cut. This nerve was mounted on a bipolar platinum wire electrode for electrical stimulation. The hindlimb muscles and nerves were covered with paraffin oil in a pool formed by the skin flaps. The ECG and heart rate were continuously monitored. Pools with mineral oil were maintained at 37--38°C using radiant heat. The *TS* muscle was connected via the Achilles tendon to the servo-control muscle puller. A linear motor under servo-control was used as the muscle puller. The muscle tension was measured by semi-conductor strain gauge resistors glued on a stiff steel beam mounted on the moving part of the linear motor. The stiffness of the puller exceeded 0.06 N/mm, whereas the time constants of the length transients did not exceed 60 ms.

To induce muscle fatigue, a series (30 min duration) of intermittent high-frequency electrical stimulations was used (**Figures [1A](#F1){ref-type="fig"}--[D](#F1){ref-type="fig"}**), separated by rest intervals of 15 min. Four stimulation series were used for the rats in group 1, and 5 stimulation series were used for the other groups of animals. Each series consisted of trains of 0.2 ms rectangular pulses at a rate of 40 s^-1^ at a 12.4 s duration, and the series were separated by 5 s intervals of rest (**Figure [1D](#F1){ref-type="fig"}**, in a circle). The stimulus current was set to 1.3--1.4 times higher than the motor threshold. At the end of the 12.4 s stimulation, the muscle was stretched, and the changes in length had a bell-shaped form (one period of 4 Hz sinusoidal signal with corresponding phase locking) with a 3.5 mm amplitude and 2 s duration (**Figure [1D](#F1){ref-type="fig"}**, bottom row in a circle). The muscle reaction to the stretching appeared to be a tension increase after continuous stimulation. These stretches were applied before the post-stimulation twitches to remove, or at least diminish, the after-effects remaining from continuous stimulation ([@B33]). The command signal to the muscle puller was derived from a DAC and was adjusted by a scaling amplifier and low-pass filter (0--100 Hz). In parallel, two analog signals (muscle tension and length) and pulse signals (stimulation pulses) were sampled via corresponding ADC channels. The signals were collected by PC using an input-output interface device (CED Power 1401) with 12-bit resolution.

![Strength of the *m. triceps surae* (*TS*) contractions during consecutive (I--IV) series of 30-min intermittent stimulations of the *n. tibialis*; the rat belongs to the fatigue-induced group of animals (group 1) **(A--D)**. The 5th individual tetanic contraction of *TS* in the IV stimulation series is presented in a circle at a higher time scale on **(D)**. P -- muscle force (Newton, N), st -- stimulation mark, L -- muscle length (stretching, mm).](fphys-09-00517-g001){#F1}

Data acquisition was performed using the program "Spike2" (CED). Input signals were digitized at rates of 5 kHz (muscle tension) and 1 kHz (other signals). Data analysis, including statistical treatment and graph plotting, was performed using the program Origin 8.0 (OriginLab Corp., United States).

Biochemical Experiment
----------------------

After acute exercise, the excised muscles (soleus and gastrocnemius) were rapidly dissected, free of fat and tendons were removed, and the muscles were divided into several portions and stored in liquid N~2~. For *GSH* (reduced glutathione) analysis, the tissue samples were transferred to a medium containing 1N perchloric acid (1:10 w/v) and homogenized with a motor-driven Potter-Elvehjem glass homogenizer. Resultant homogenate was centrifuged at 10,000 *g* for 10 min (4°C). *GSH* content was measured spectrophotometrically ([@B66]). For the activities of enzymes, *H*~2~*O*~2~ and lipid peroxidation assays, the muscle samples were thawed and homogenized in 50 mM phosphate buffer with 2 mM *EDTA* (pH 7.4) at 4°C (1:9 w/v). The homogenates were then centrifuged then for 15 min at 15,000 *g* (4°C), and the post-mitochondrial supernatant was stored at -70°C.

Oxidative damage in tissue was measured using a *TBARS* assay. *TBARS* were isolated by boiling tissue homogenates for 15 min at 100°C with thiobarbituric acid reagent (0.5% 2-thiobarbituric acid/10% trichloroacetic acid/0.63 M/dm^3^ hydrochloric acid) and measuring the absorbance at 532 nm. The results were expressed as nM *TBARS*/mg protein using 𝜀 = 1.56 × 10^5^ dm^3^/M/cm ([@B12]). The data on ROS formation were obtained from dichlorofluorescein (DCF) fluorescence. The tissue homogenates were loaded for 20 min at 37°C with non-fluorescent probe (2′,7′-dichlorodihydrofluorescein diacetate, DCFHDA) which is known to be decomposed in cells to give dichlorofluorescein upon oxidation by ROS, primarily hydroperoxide and superoxide anion. The final concentration of DCFH-DA was 10 μM. DCF formation was followed at the excitation wavelength of 488 nm and emission wavelength of 525 nm for 30 min by using a Hitachi F-2000 fluorescence spectrometer. The rate of DCFH-DA conversion to DCF was linear for at least 60 min, corrected with the autoxidation rate of DCFH-DA without protein. All assays were carried out in duplicates. Fluorescence was expressed as arbitrary fluorescence units.

*H*~2~*O*~2~ concentration in the tissue homogenates was measured using the FOX method, which is based on the peroxide-mediated oxidation of Fe^2+^, followed by a reaction of Fe^3+^ with xylenol orange (o-cresolsulfonephthalein 3′,3^′′^bis\[methylimino\] diacetic acid, sodium salt). This method is extremely sensitive and used to measure low levels of water-soluble hydroperoxide present in the aqueous phase. To determine the *H*~2~*O*~2~ concentration, 500 μL of the incubation medium was added to 500 μL of assay reagent (500 μm ammonium ferrous sulfate, 50 mm *H~2~SO~4~*, 200 μm xylenol orange, and 200 mm sorbitol). The absorbance of the *Fe^3^*^+^-xylenol orange complex (*A*~560~) was detected after 45 min. Standard curves of *H*~2~*O*~2~ were obtained for each independent experiment by adding variable amounts of *H*~2~*O*~2~ to 500 μL of basal medium mixed with 500 μL of assay reagent. The data were normalized and expressed as μm *H*~2~*O*~2~ per mg protein ([@B82]).

Catalase activity was measured by decomposition of H~2~O~2~, which was determined by a decrease in absorbance at 240 nm ([@B1]).

Reduced glutathione was determined using Ellman's reagent. One milliliter of supernatant was treated with 0.5 ml of Ellman's reagent (5.5′-dithio-bis-nitrobenzoic acid in abs. ethanol) and of 0.4 M *Tris HCl* buffer with 2 mM *EDTA*, pH 8.9. The absorbance was read at 412 nm in a spectrophotometer ([@B66]).

Manganese-superoxide dismutase (*Mn-SOD*) activity was estimated by the method of [@B42], which is based on the inhibition of autoxidation of adrenaline to adrenochrome by the *SOD* contained in the examined samples. The mitochondrial samples were preincubated at 0°C for 60 min with 6 mM *KCN*, which produces total inhibition of *Cu*, *Zn-SOD* activity. The results were expressed as the specific activity of the enzyme in units per mg protein. One unit of *SOD* activity was defined as the amount of protein causing 50% inhibition of the conversion rate of adrenaline to adrenochrome under specified conditions.

The activity of selenium-dependent *GPx* was determined according to the method of [@B18]. Briefly, the reaction mixtures consisted of 50 mM *KPO~4~* (pH 7.0), 1 mM *EDTA*, 1 mM *NaN~3~*, 0.2 mM *NADPH*, 1 mM *GSH*, 0.25 mM *H*~2~*O*~2~, and 226 U/ml glutathione reductase, and the rates of *NADPH* oxidation followed at 340 nm.

Lactic acid was determined in muscle tissue after deproteinization with 6% (wt/wt) perchloric acid by sitting the tissue on ice for 15 min and then centrifuging the tissue at 14,000 *g* for 5 min. The supernatant was neutralized with 5 M *K~2~CO~3~*, clarified again to remove potassium perchlorate, and stored at -70°C. The assay mixtures contained glycine/*EDTA*/hydrazine hydrate buffer (pH 9.5), 0.05 mM *NAD*, 10 units of lactate dehydrogenase, and sample (100 μl), and the mixtures were incubated at 37°C for 20 min. The *LA* concentration was determined spectrophotometrically at 340 nm in a 1.0-ml total reaction volume ([@B27]).

Protein concentration was estimated with the Bradford method using bovine serum albumin as a standard. All chemicals were purchased from Sigma, Fluka and Merck and had the highest available purity.

Statistical Analysis
--------------------

In the electrophysiological study, each stimulation series was averaged (100 stimulations in one series). The average value of the first series was set to 100%, and the other series were normalized in relation to this and presented graphically for one of hindlimb. During experiments, it was found that till the moment of a drastic decrease of TS contraction force control animals maintain a certain force level of muscular contraction only during three series of electrical stimulation. To confirm the muscle fatigue factor, data from four stimulation series were taken for the study. Some animals from groups 3--6 to maintain a certain force level of muscular contraction until 5--6 series of electrical stimulation. Therefore, for further analysis, data from the first 5 series were taken.

Mean values (mean ± SD) of the *TS* muscle strength after C~60~FAS, NAC, β-Alanine, saline solution induction or without any induction were compared using two-way statistical analysis of variance (ANOVA). The factors of variation included two conditions: time and the effects of the C~60~FAS (NAC, β-Alanine or non-injected). A Bonferroni *post hoc* analysis was used to determine the differences between groups. The level of significance was set at *P* \< 0.05.

Biochemical data are expressed as the means ± SEM for each group. The differences among experimental groups were detected by one-way analysis of variance (ANOVA) followed by Bonferroni's multiple comparison test. Values of *P* \< 0.05 were considered significant.

Results
=======

It has been established that the size of water-soluble C~60~ fullerene particles directly correlates with their cytotoxicity and biological properties ([@B38]; [@B52]; [@B73]; [@B34]; [@B84]). Depending on the size, water-soluble C~60~ fullerene particles can penetrate through the plasma membrane into the cell or be adsorbed on the surface of the membrane ([@B19]; [@B65]; [@B20]). In this regard, the main advantage of using pristine C~60~ fullerenes as powerful antioxidants ([@B21]; [@B53]) is their ability to be localized preferentially to mitochondria, which generates a substantial amount of cellular ROS ([@B19]; [@B83]). Thus, since the size of C~60~ fullerene particles and stability of their aqueous solution (the degree of aggregation in water) may influence their bioactivity, the DLS and zeta potential studies of C~60~FAS were performed.

DLS and Zeta Potential Studies
------------------------------

The DLS results for investigated C~60~FAS clearly demonstrate that there was a monomodal nanoparticle size distribution in a (15--30) nm range, i.e., these nanoparticles in particular have specific bioactivity. This result is similar to our previous probe microscopic data, which directly correlate with C~60~ fullerene bioactivities ([@B51]; [@B72]).

The magnitude of the zeta potential is related to the stability of colloid dispersions because it determines the degree and nature of the interaction between the particles of the dispersal system. The value of zeta potential for C~60~FAS was equal to -23 mV, which agrees well with our previously published data ([@B59]). A high negative charge for colloid nanoclusters (or, more strictly, the electrostatic repulsion between the negatively charged nanoclusters) seems to play a significant role in the stabilization of C~60~FAS (i.e., it disfavors the aggregation and makes the solution electrically stable).

Electrophysiological Experiments
--------------------------------

As a result of intermittent high-frequency electrical stimulation (30 min duration, 40 Hz) of *TS* muscle in the rats of the first and second groups during four series, the reduction of the force contraction was recorded until the muscle ceased to demonstrate clear contractions. **Figure [1](#F1){ref-type="fig"}** shows an example of the *TS* force response changes in one animal of the first group during fatigue development. In this case, the dynamics of changes in muscle force reflected fatigue development and a drop in amplitude in single contractions. In the first series of stimulations, a gradual reduction of *TS* activity level was observed over 30 min. In the second series of stimulations, which were started after a 15 min rest, the amplitudes of tetanic contractions were somewhat recovered; however, they did not reach the initial level, continuing to decrease. Within the third series of stimulations (after 90 min of electrical stimulation), an abrupt drop in the muscle force was observed. Within this time interval, the maximum significant strength level decrease (*P* \< 0.05) was observed with respect to the first series of stimulations (**Figure [2](#F2){ref-type="fig"}**). After another interruption between stimulations, the isometric muscle force contraction continued to decline without further recovery. At the same time, such a decrease in muscle force response was statistically significant (*P* \< 0.05) within the IV series of stimulations with respect to that one in the I, II, and III series (**Figure [2](#F2){ref-type="fig"}**). Note that statistically significant differences (*P* \> 0.05) in the strength of muscle contractions between rats in groups 1 and 2 were not found.

![Changes in the *TS* muscle strength in the I--IV series of fatigue stimulation. There are normalized averaged force (mean ± SD) (normalization with respect to the first series) values. The averaging procedure has been applied to the data registered in six animals of the fatigue-induced group of rats (group 1), and the data were averaged with respect to the corresponding stimulation series. Asterisks denote significant differences (*P* \< 0.05) between the muscle strength of different electrical stimulation series.](fphys-09-00517-g002){#F2}

For assessments of the effectiveness of administration method of the C~60~FAS under conditions of fatigue stimulation it was made a comparison of the changes in the force levels developed by muscles in animals with C~60~ fullerene i.p. injection (F-injection) and in animals that drank C~60~ fullerene for 5 days (F-drinking) (**Figure [3](#F3){ref-type="fig"}**). The analysis did not reveal any significant differences in the muscle strength after studying the effects of these substance administration methods on muscle fatigue (F-injection vs. F-drinking). In this case, under conditions of both F-injection and F-drinking, the muscle maintained the same constant force level during the first series of fatigue stimulation (30 min). In animals with a C~60~ fullerene i.p. injection during the third series of stimulations, the force level was slightly higher compared to the group of animals that drank C~60~FAS. Under conditions of further fatigue stimulation (V series) with F-injection and F-drinking, the difference in the level of the developed effort decreased (**Figure [3](#F3){ref-type="fig"}**). Thus, the absence of statistically significant differences (*P* \> 0.05) made it possible for us to conduct further analyses of fatigue development using only F-drinking administration, since it is non-invasive and potentially more practical for future application.

![Averaged characteristics (mean ± SD) of the normalized (with respect to the first stimulation series) values of the muscle strength after preliminary intraperitoneal injection and oral administration of C~60~FAS (*dark gray* and *light gray bars*, respectively). I, III, and V -- series of electrical fatiguing stimulation. Values of six animals in each group were averaged according to stimulation series. Note the absence of significant differences between data obtained in rats of groups 3 and 4.](fphys-09-00517-g003){#F3}

Further analysis suggested the force fatigue contractions on the background of a separate action of C~60~FAS attach be compared to exogenous antioxidants NAC and β-Alanine (**Figure [4](#F4){ref-type="fig"}**). The data obtained in these experiments (**Figures [4B,F](#F4){ref-type="fig"}**) indicate that a reduction in the developed force in the animals of the F-drinking, the NAC-injected and the β-Al-injected group was slower compared to fatigue-induced or vehicle-injected animals. Significant differences (*P* \< 0.05) in muscle strength changes between control animals (groups 1 and 2) and experimental rats (groups 4--6) appeared after the second stimulation series. In groups 4--6, the muscle maintained a constant level of developed effort through the whole fatigue stimulation, which was demonstrated using native records of its force characteristics (**Figures [4A,C,E](#F4){ref-type="fig"}**). The animals of the F-drinking group held a stationary level of force longer than the NAC-injected and β-Al-injected animals. The dynamics of the force changes was similar in almost all animals of this group (**Figure [4B](#F4){ref-type="fig"}**). In the NAC-injected animals during the III series, there was decrease in the muscle strength amplitude along with further stabilization, but these effects were not significant (**Figure [4C](#F4){ref-type="fig"}**). It should be noted that in two animals of this experimental group, recovery of the muscle contraction force level to the force level at the initial fatigue stimulation stages occurred (**Figures [4C,D](#F4){ref-type="fig"}**). At the same time, in the F-drink group during the V series of fatigue stimulation, muscle strength recovery was also observed, and in some animals, its increase was recorded (**Figure [4B](#F4){ref-type="fig"}**). In the β-Al-injected group, the developed force was maintained at a steady-state level within each series of stimulations (**Figure [4E](#F4){ref-type="fig"}**). At the end of the I series of stimulation, there was a slight decrease in muscle force with some recovery in the III series of stimulations. However, during further stimulation (V series), the level of the muscle force was slightly lower compared to previous series (**Figure [4E](#F4){ref-type="fig"}**). In this case, in all animals of this experimental group a similar change in muscle force was observed (**Figure [4F](#F4){ref-type="fig"}**).

![Strength of the muscle contractions after preliminary oral administration of C~60~FAS and injection of NAC and β-Alanine. **(A,C,E)** Protocol of registration of the muscle contractions after preliminary C~60~FAS oral administration, NAC- and β-Al-injection, respectively; **(B,D,F)** -- results of six fatigue tests in the groups of animals with preliminary C~60~FAS oral administration, NAC- and β-Al-injection, respectively. I, III, and V -- series of electrical fatigue stimulations, P -- muscle force (Newton, N), st -- stimulation mark, L -- muscle length (stretching).](fphys-09-00517-g004){#F4}

To compare the action of the C~60~FAS and antioxidants on the force of contractions during fatigue development, a statistical analysis was performed (**Figure [5](#F5){ref-type="fig"}**). In NAC-injected animals, during the initial series of stimulation, there was maintenance of the force at a constant level followed by some decrease. The characteristics of fatiguing muscle contractions were somewhat different in the F-drinking group. In these experiments, the level of muscle force, after some initial reduction in the I series of stimulations, was further recovered and almost reached the control values. In the β-Al-injected group, a gradual decrease of the muscle force was observed. However, it should be noted that there was no significant difference in the muscle force for series conducted within the same animal group, as well as between groups (NAC-injected, F-drink, β-Al-injected) (**Figure [5](#F5){ref-type="fig"}**).

![Averaged characteristics (mean ± SD) of normalized (with respect to the average values in the first stimulation series) values of the muscle strength after preliminary C~60~FAS oral administration, NAC- and β-Al-injection. Values of six animals in each group were averaged by stimulation series. Note the absence of significant differences between the data obtained in the rats of these groups. I, III, and V -- a series of electrical fatigue stimulations.](fphys-09-00517-g005){#F5}

Biochemical Experiments
-----------------------

After the fatiguing tests, accumulation of secondary products and changes in antioxidant levels in the muscle tissues were determined (**Figure [6](#F6){ref-type="fig"}**). The obtained data clearly demonstrate the increased level of metabolic product (*LA*), markers of peroxidative and oxidative stress (*TBARS*, *H*~2~*O*~2~) and ROS formation after stimulation that indicates the occurrence of muscle fatigue (**Figure [6](#F6){ref-type="fig"}**). This increase was statistically significant with respect to the intact muscles ("*norm"*) and consisted of 61% for ROS formation, 78% for *TBARS*, 115% for *H*~2~*O*~2~, and 198% (*P* \< 0.05) for *LA*. In turn, in response to these changes in the working muscle, there was a significant (*P* \< 0.05) increase in endogenous antioxidant activity, including *GSH* (71%), *CAT* (18%), *GPx* (28.5%), and *SOD* (34%).

![Indicators of the prooxidant-antioxidant balance in the *m. triceps surae* (*TS*) of rats. ROS formation **(A)**, the concentration of thiobarbituric acid reactive substances (*TBARS*) **(B)**, hydrogen peroxide (*H*~2~*O*~2~) **(C)**, lactic acid (*LA*) **(D)**, reduced glutathione (*GSH*) **(E)**, catalase (*CAT*) **(F)**, glutathione peroxidase (*GPx*) **(G)** and superoxide dismutase (*SOD*) **(H)** are in intact animal muscles (norm), *TS* fatigue-induced animals (fatigue) and *TS* fatigue-induced animals after C~60~FAS oral administration (C~60~FAS), NAC-injection (NAC) and β-Al-injection (β-Alanine), respectively. Values are the means ± SEM, *n* = 6. ^∗^*P* \< 0.05 vs. "norm"; ^\#^*P* \< 0.05 vs. "fatigue."](fphys-09-00517-g006){#F6}

In animals that drank C~60~FAS, ROS formation and concentrations of *TBARS*, *H*~2~*O*~2~ and *LA* were significantly lower at 24.1, 36.1, 27.8, and 13.1% (*P* \< 0.05), respectively, compared to the "*fatigue"* group. Similar changes in the level of these marker concentrations were also observed in the NAC-injection and β-Al-injection groups. A similar dynamic has been revealed in changes in the activity of antioxidant enzymes. Under conditions of fatigue development, the level of *GSH*, *CAT*, *GPx*, and *SOD* activity significantly increased by 71.4, 18.6, 28.5, and 34.2% relatively to the "*norm,"* respectively. The animal groups F-drinking, NAC-injection and β-Al-injection showed a decrease in endogenous antioxidants activity relative to the "*fatigue"* group (*P* \< 0.05). Furthermore, in rats that drank C~60~FAS, the activity levels of *GSH*, *CAT*, and *GPx* were smaller.

Discussion
==========

In this study, we compared the effects of an aqueous colloid solution of pristine C~60~ fullerene with the action of the NAC and β-Alanine on exercise tolerance and contractile properties of rat *TS* during development muscle fatigue. This experimental approach allowed us to analyze and compare the characteristics of the force parameter changes of muscle contraction under conditions with the same fatigue stimulation pattern applied after oral introduction of C~60~FAS or separate i.p. injections of C~60~FAS, NAC and β-Alanine. The results showed a statistically significant reduction in muscle force in all animals without prior administration of C~60~FAS, NAC, and β-Alanine (**Figure [2](#F2){ref-type="fig"}**). To maintain the normal functional and physiological state of the muscle during the dynamic work performance, the duration of its recovery and active rest are very important factors ([@B26]). An insignificant decrease in the muscle contraction force compared to the control occurred in animals that drank C~60~FAS and in both NAC- or β-Al-injected rats (**Figure [5](#F5){ref-type="fig"}**). This outcome supported our previous finding that fullerene can lower the effects of fatigue development and promote force maintenance at a constant level ([@B55]). At the same time, in most animals of the F-drinking group, there was a recovery of the force level after some decrease, whereas in the NAC- and β-Al-injected groups, only an insignificant decline occurred (**Figures [4B,D,F](#F4){ref-type="fig"}**). A definite recovery of the contractile ability was noticed in only two animals from the NAC-injected group (**Figure [4D](#F4){ref-type="fig"}**). These data on the effects of C~60~FAS as a potent antioxidant under fatigue development conditions are in accordance with the data that were obtained earlier ([@B55]). In this case, one can speak about the predominant influence of C~60~ fullerene on muscle strength characteristics during fatigue development compared to the action of other investigated exogenous antioxidants, such as NAC or β-Alanine.

In our study, we showed that fatigue stimulation in the working muscle led to an increase in the metabolic products (*LA*) and the intensification of the oxidative processes, a namely a significant increase in ROS formation and lipid peroxidation, which occurs simultaneously with an increase in *CAT* and *GSH* activity in both fast and slow twitch muscles fibers relative to the intact muscle (**Figure [6](#F6){ref-type="fig"}**). The increased *LA* level further reduced the pH, which could induce various biochemical and physiological effects during muscular contractions, including glycolysis, phosphofructokinase, and calcium release ([@B80]). Therefore, *LA* is an important marker for evaluate the degree of fatigue of a living organism. In the group of animals that drank C~60~FAS, attenuation of oxidative stress was observed (i.e., a decrease in ROS generation and TBARS concentration). This outcome was confirmed by the data obtained earlier on the effects of C~60~ fullerenes for the prooxidant--antioxidant homeostasis of rat muscle tissue ([@B55]). Similar changes in the number of metabolites and peroxide oxidation markers were observed in the NAC-injected and β-Alanine-injected groups. It has been supported that β-Alanine supplementation increases carnosine levels and decreases lactate responses after high-intensity exercise in rat muscles ([@B15]). In skeletal muscles, carnosine acts as a pH buffer and functions as an antioxidant ([@B9]), which suggests that there is a potential role for carnosine for reversing or limiting the effects of oxidative stress and cellular senescence. Therefore, it cannot be excluded that the β-Alanine intake results in decrease of lactate and H^+^-ion production. The skeletal muscles from NAC-injected rats showed a low content of *TBARS*, suggesting a reduced muscle fiber disruption due to cell membrane lipid peroxidation as compared with non-injected rats. This protective effect of NAC is due to direct scavenging of ROS and *GSH* synthesis enhancement ([@B5]; [@B76]; [@B69]).

The important role of *GSH* in protecting against exercise-induced oxidative stress has been demonstrated in several studies ([@B70]; [@B37]). The increased amount of *GSH* in the stimulated muscle (without the C~60~FAS, NAC, or β-Alanine administration and after their application) indicates compensatory activation of the endogenous *GSH* antioxidant system on the action of the stimulus (**Figure [6E](#F6){ref-type="fig"}**). In some studies, it has been shown that during intense loads, there is a significant decrease in *GSH* content in *m. soleus* and an increase in *GSH* content in *m*. *deep vastus lateralis* (*DVL*), but did not alter *GSH* status in the liver or plasma ([@B37]). Although other studies indicate an increase in the concentrations of *GSH* and *GSSG* in *m. soleus*, less in *DVL* and *m. superficial vastus lateralis* (*SVL*). However, the *GSSG*/*GSH* ratio does not change significantly because *GSSG* can be reduced to *GSH* by glutathione reductase. Furthermore, exercising skeletal muscles appear to increase GSH import from plasma ([@B31]) as well as the synthesis of *GSH* in the liver from endo- or exogenous amino acids, which adds most of the circulating *GSH* ([@B41]), that ensures plasma GSH homeostasis despite enhanced tissue *GSH* use. Our experiments showed an increase in *GSH* activity during fatigue and a decrease in *GSH* under the actions of C~60~FAS, NAC, or β-Alanine. This outcome is consistent with the data of other authors who have shown that the use of NAC, in particular, decreases exercise-induced *GSSG*, and blood lipid peroxidation in rats ([@B70]) improves muscle contractile functions as well as reduces low frequency fatigue in the diaphragm muscle ([@B71]) and human leg muscles ([@B58]).

An increase in the level of *H*~2~*O*~2~ activity during muscle contractions led to an increase in the *CAT* enzyme concentration (**Figure [6F](#F6){ref-type="fig"}**). These data also support studies performed earlier in rats ([@B30]; [@B28]). It was shown that CAT activities were significantly elevated after exhaustive exercise with or without hydroperoxide injection in muscle and not in liver ([@B30]). Previously, it was reported that after the acute stage of the exercise, *CAT* was significantly higher in *m. soleus* than in *DVL* and *SVL*. Furthermore, the exercise at moderate intensities elicited significant increases in *CAT* activity in *DVL* ([@B31]). However, some studies have reported no changes in muscle *CAT* with training ([@B46]; [@B56]), and a few studies even reported a decrease in *CAT* activities in *m. soleus* of the adult and old rats ([@B36]). In our study, during fatigue under NAC or β-Alanine treatment, the effects of *CAT* activity decreased with respect to "*fatigue,"* but exceeded the control values. However, in animals that drank C~60~FAS, *CAT* activity remained at the control level, which indicated that there was a greater compensatory effect of C~60~ fullerenes.

An increase in the concentration of oxidative process markers led to an increase in the activity of *GPX* in the working muscle (**Figure [6G](#F6){ref-type="fig"}**). However, with using of NAC and β-Alanine, the activity of this enzyme decreased relatively to "*fatigue,"* and in the group of F-drinking, it was practically restored to normal. Data about *GPX* activity remain controversial. [@B46] showed an increase in *GPX* activity in red *m. gastrocnemius* after endurance training in rats, whereas *m. soleus* and white *m. gastrocnemius* revealed no training effect. The magnitude of the GPX increase was directly related to exercise duration but independent of intensity. Thus, the *GPX* activity has demonstrated variable responses to acute exercise for various types of skeletal muscles. For example, *GPX* activity increased the next day after running on the treadmill until exhaustion in the *m. soleus* of rats, but not in *m. tibialis* ([@B56]). In our study, the activity level of *GPX* under fatigue conditions in the F-drinking group may indicate that C~60~FAS, by affecting endogenous antioxidants, prevents fatigue in an actively contracting muscle better than NAC and β-Alanine.

It has been proved that C~60~ fullerenes normalize cellular metabolism and nervous processes by increasing resistance to stress, increase the activity of enzymes and regenerative capacity of tissues, and also exhibit pronounced anti-inflammatory and antiallergenic effects ([@B14]) and effectively regulate the ATPase activity of actomyosin ([@B3]). It has been experimentally found that C~60~ fullerenes and their derivatives may be auxiliary agents in complex therapy due to their ability to intensify the protective functions of the immune and antioxidant systems of the body ([@B6]; [@B17]; [@B24]). In this regard, the above electrophysiological and biochemical results suggest a real perspective for the use of water-soluble pristine C~60~ fullerenes as potential agents for improving the efficiency of human skeletal muscle functioning by modifying ROS-dependent mechanisms that play an important role in the development of muscle fatigue.

It was shown that under intense loads in skeletal muscles, the activity of *SOD* increases ([@B30]; [@B31]; [@B35]). We investigated the isoenzyme located in the mitochondria and *Mn^2^*^-^ contained in the active center ([@B81]). Under the conditions of the fatiguing tests, the activity of *Mn-SOD* increased, and after application of the test substances, it decreased approximately to same level, insignificantly exceeding the control value. These results were confirmed by the data of [@B56], where it was shown that in rats after the exhausted treadmill run, the immunoreactive content and activity of both isoenzymes of *SOD* (*Mn-SOD* and *Cu*, *Zn-SOD* are found in the cytoplasm, in erythrocytes and liver ([@B40]) increased in the *m. soleus* and *m. tibialis* immediately after the run. In animals that had been previously injected by the antioxidant, attenuation of oxidative stress was observed (i.e., a decrease in *TBARS* concentration). An increase in *Mn-SOD* was noted even in 1 day after the load in hepatic tissue ([@B57]). Additionally, it was shown that during intense swimming training, myocardial and diaphragmatic *SOD* were induced in rats ([@B48], [@B47]). [@B45] showed that an adequate physical endurance load increases both the activity and the content of *Mn-SOD* and that untrained rats are very sensitive to oxidative stress during exercise. *Mn-SOD* is a reliable indicator of physical condition. It is concluded that the muscles can react to the load in such way to reduce the damage that results from the accumulation of free oxygen radicals due to increased metabolic activity.

Conclusion
==========

It should be noted that there are studies in humans and animals demonstrating both various exogenous antioxidants and submaximal long-term training. The training increases the activity of endogenous antioxidants ([@B48], [@B46]) and the antioxidant defense system of glutathione ([@B8]) in skeletal muscles, which reduces the risk of cell damage, improving performance, and slowing down the muscle fatigue. Recent studies show that the addition of some antioxidant nutrients is necessary for physically active people ([@B67]; [@B50]; [@B8]).

The results obtained in this study confirm previous data on the mechanism of action of C~60~FAS intramuscular injections ([@B55]). A comparative analysis was produced using a non-invasive method for C~60~FAS administration, demonstrating a similarity of action of C~60~FAS with effects of already known exogenous antioxidants NAC and β-Alanine. But due to its membranotropic activity and the lack of acute *in vivo* toxicity (at least at low physiological concentrations), C~60~ fullerene has a greater effective influence on the homeostasis of muscle tissue in rats, which maintains the normal physiological state of the muscle and increases the duration of its active work.
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C~60~FAS

:   pristine C~60~ fullerene aqueous colloid solution

CAT

:   catalase

GPx

:   glutathione peroxidase

GSH

:   reduced glutathione

H~2~O~2~

:   hydrogen peroxide

NAC

:   antioxidants *N*-acetylcysteine

SOD

:   superoxide dismutase

TBARS

:   thiobarbituric acid reactive substances

TS

:   *m. triceps surae*
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